日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Characteristics, Treatment Patterns and Outcomes of Patients with Pulmonary Arterial Hypertension by Race and Ethnicity Using Real-World Data from the Combined OPUS/OrPHeUS Studies

利用OPUS/OrPHeUS联合研究的真实世界数据,分析不同种族和民族的肺动脉高压患者的特征、治疗模式和预后

Melendres-Groves, Lana D; Channick, Richard N; Chin, Kelly M; McLaughlin, Vallerie V; MacDonald, Gwen; Martin, Nicolas; Ong, Rose; Sandros, Marinella; Kim, Nick H

Meaningful within-person change estimates do not identify responders to treatment

有意义的个体内部变化估计值无法识别治疗反应者

Channick, Jessica E; Hays, Ron D

Are we ready for home spirometry for systemic sclerosis-associated ILD?

我们是否已准备好将家庭肺功能测定应用于系统性硬化症相关间质性肺病的诊断?

Channick, Jessica; Volkmann, Elizabeth R

Progression of interstitial lung disease after the Envisia Genomic Classifier

Envisia基因组分类器后间质性肺病的进展

Chung, Augustine; Oh, Andrea; Durant, Catherine; Watson, Richard; Channick, Jessica; Fishbein, Greg; Pourzand, Lila; Kim, Sharon; Ronaghi, Reza; Oh, Scott; Kim, Grace; Weigt, S Sam

Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension Study

塞拉鲁替尼治疗成人肺动脉高压:TORREY开放标签扩展研究

Sitbon, Olivier; Sahay, Sandeep; Escribano Subías, Pilar; Zolty, Ronald L; Kingrey, John F; Ryan, John J; Sobol, Irina; Sood, Namita; Benza, Raymond L; Channick, Richard N; Chin, Kelly M; Frantz, Robert P; Ghofrani, Hossein-Ardeschir; Hemnes, Anna R; McLaughlin, Vallerie V; Vachiéry, Jean-Luc; Zamanian, Roham T; Ter Veer, Anna; Roscigno, Robert F; Mottola, David; Parsley, Ed; Aranda, Richard; Zisman, Lawrence S; Howard, Luke S

Macitentan and Tadalafil Combination Therapy in Patients with Pulmonary Arterial Hypertension and Cardiovascular Comorbidities: Real-World Evidence from OPUS and OrPHeUS

马西替坦和他达拉非联合治疗合并心血管疾病的肺动脉高压患者:来自OPUS和OrPHeUS的真实世界证据

Kim, Nick H; Chin, Kelly M; McLaughlin, Vallerie V; Ong, Rose; MacDonald, Gwen; Martin, Nicolas; Senatore, Assunta; Channick, Richard

In Situ Pulmonary Artery Thrombosis and Low Flow Stasis Artifact in Parenchymal Lung Disease: An Under-Recognized Phenomenon

肺动脉血栓形成及肺实质疾病中的低流量淤滞伪影:一种未被充分认识的现象

Mansour, Jennifer; Dekitani, Ken; Abtin, Fereidoun; Saggar, Rajan; Channick, Richard

Case report: Use of sotatercept to treat pulmonary arterial hypertension in a patient with hereditary hemorrhagic telangiectasia

病例报告:应用索他西普治疗遗传性出血性毛细血管扩张症患者的肺动脉高压

Ramakrishnan, Abinaya; Olitsky, Scott; Saggar, Rajan; Channick, Richard N; McWilliams, Justin P

Case report: Successful use of sotatercept to treat pulmonary arterial hypertension in a patient with hereditary hemorrhagic telangiectasia

病例报告:索他西普成功治疗遗传性出血性毛细血管扩张症患者的肺动脉高压

Ramakrishnan, Abinaya; Olitsky, Scott; Saggar, Rajan; Channick, Richard N; McWilliams, Justin P

Effects of macitentan and selexipag across prognostic age groups in patients with pulmonary arterial hypertension

马西替坦和司来帕格对不同预后年龄组肺动脉高压患者的影响

Channick, Richard; Medrek, Sarah; Delcroix, Marion; Gaine, Sean; Jansa, Pavel; Lang, Irene; McLaughlin, Vallerie; Mehta, Sanjay; Pulido, Tomas; Sastry, Bhagavatula; Souza, Rogerio; Torbicki, Adam; Zhao, Carol; Strachan, Paul; Agron, Peter; Yen, Joseph; Sitbon, Olivier